ABEONA THERAPEUTICS INC. Class of Warrant or Right, Outstanding
ABEONA THERAPEUTICS INC. (ABEO) had Class of Warrant or Right, Outstanding of 5.76 million shares as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-17
- 2025-12-31: Class of Warrant or Right, Outstanding 5.76M shares.
- 2024-03-31: Class of Warrant or Right, Outstanding 1.79M shares.
- 2023-12-31: Class of Warrant or Right, Outstanding 1.79M shares.
- 2023-09-30: Class of Warrant or Right, Outstanding 1.79M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2025-12-31 | 5.76M shares 10-K · filed 2026-03-17 |
| 2024-03-31 | 1.79M shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 1.79M shares 10-K · filed 2024-03-18 |
| 2023-09-30 | 1.79M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 1.79M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 1.79M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 1.79M shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 1.79M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 1.79M shares 10-Q · filed 2022-08-11 |
| 2019-12-31 | 70.00K shares 10-K · filed 2020-03-16 |
| 2018-12-31 | 1.82M shares 10-K · filed 2019-03-18 |
| 2017-12-31 | 2.93M shares 10-K · filed 2018-03-16 |
| 2016-12-31 | 3.74M shares 10-K · filed 2017-03-30 |
| 2015-12-31 | 3.80M shares 10-K · filed 2016-03-30 |
| 2014-12-31 | 4.16M shares 10-K · filed 2015-03-31 |
| 2013-12-31 | 31.88M shares 10-K · filed 2014-03-26 |
| 2012-12-31 | 35.73M shares 10-K · filed 2013-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |